Real-time enrollment status for this dravet syndrome clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:07 PM UTC
| NCT Number | NCT06660394 |
| Recruiting Status | Recruiting |
| Condition | Dravet Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 160 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Longboard Pharmaceuticals |
| Last Updated on CT.gov | June 12, 2026 (Jun 12, 2026) |
As of July 17, 2026: Clinical trial NCT06660394 is currently recruiting participants. This phase3 study for dravet syndrome is actively seeking new participants at 24 locations across the United States. The study is sponsored by Longboard Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06660394 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06660394 was last updated Jun 12, 2026 (June 12, 2026). HelloStudys verifies this status automatically.